Advancing Precision Oncology Across the Breast Cancer Journey

A breast cancer diagnosis can leave people with more questions than answers. Understanding what comes next—and what options are available—can make an important difference.

That’s why Abbott Cancer Diagnostics is proud to partner with Susan G. Komen to expand access to trusted, evidence-based education about precision oncology. Together, we’re helping people affected by breast cancer better understand the role of biomarker testing and how it may help inform treatment decisions at different points in their care.

Our shared goal is simple: make complex science easier to understand so patients feel more informed, more empowered and more confident having conversations with their health care team. By combining Susan G. Komen’s longstanding commitment to patients with Abbott’s expertise in precision oncology, we’re working to ensure every person facing breast cancer has access to information that supports more personalized care.

About Abbott Cancer Diagnostics

The Difference Knowing Makes
Ours isn’t only a story about science—it’s a story about people. It’s about what happens when knowing replaces fear, when answers arrive in time to change what comes next and when scientific progress becomes deeply personal.

As science continues to evolve, so will we. Guided by curiosity and care, we’ll keep listening, learning and leading, pushing boundaries to bring better answers to everyone facing cancer. Today, our tests span the spectrum of cancer care, from risk to remission. Together, they tell a story, one of people everywhere gaining answers sooner, acting faster and living longer, fuller lives.

Our progress isn’t just measured in data points or lab results. It’s measured in birthdays celebrated, family photos taken and hugs between friends. At Abbott, we believe that’s what knowing can do. And we’re just getting started.